RESUMEN
The slipper oyster Magallana bilineata (Ostreidae) is considered as culinary delicacy among marine bivalves, and a sulphated glycosaminoglycan, 4,6-O-SO3-ß-(1â3)-GalNAcp (unit A) and ß-(1â4)-GlcAp (unit B) as principle structural motif containing laterally branched 4-O-SO3-ß-glucopyranose (unit C) (MBP-3) was isolated from this species. Nuclear magnetic resonance (NMR), Fourier transform infra-red (FTIR), and mass spectroscopy techniques were used to characterise MBP-3. MBP-3 exhibited anti-inflammatory activities against inflammatory 5-lipoxygenase (IC50 0.11 mg mL-1) and cyclooxygenase-2 (IC50 0.12 mg mL-1) enzymes. MBP-3 (at 100 µg mL-1) showed effective downregulation against pro-inflammatory cytokines generation, namely interleukins-6, 1ß, (IL-6, 1ß) (1-1.7 pg mL-1) and tumour necrosis factor-α (TNF-α) (4 pg mL-1) along with substantial downregulation of ROS production in lipopolysaccharide (LPS)-inflamed cells. MBP-3 blocked the mRNA of NF-κB, cyclooxygenase-2 (COX-2), and other cytokines, in lipopolysaccharide-induced macrophages. The potential to constrain inflammatory cytokine production revealed its application to develop functional food to attenuate inflammation-associated disorders.
RESUMEN
Sulfated polysaccharides are effective immunostimulating agents by activating several intracellular signaling pathways. A sulfated (1 â 3)/(1 â 4)-linked galactofucan TCP-3 with promising immunomodulatory effects was purified from a marine macroalga Turbinaria conoides. The immune-enhancing potential of TCP-3 (100-400 mg/kg BW) was evaluated on cyclophosphamide-induced immunosuppressed animals by increasing bone marrow cellularity (10-13 cells/femur/mL x 106), α-esterase activity (1200-1700 number of positive cells/4000 BMC), interferon-γ (1.31-1.49 pg/mL), interleukin-2 (3.49-3.99 pg/mL) secretion, and WBC count (> 3000 cells/cu mm). The proliferation of lymphocytes for in vitro and in vivo conditions was enhanced by administering TCP-3 besides regulating the secretion of pro-inflammatory cytokines (interleukin-6/1ß/12, tumor necrosis factor-α, transforming growth factor-ß), and an inducible isoform of nitric oxide synthase. A promising reduction of viral copy formation was observed by administering TCP-3 (< 2 × 107 number) on SARS CoV-2 (delta variant) induced Vero cells in comparison with the infected group (> 5 × 107 number).
Asunto(s)
COVID-19 , Phaeophyceae , Algas Marinas , Animales , Chlorocebus aethiops , Sulfatos , Células Vero , SARS-CoV-2RESUMEN
Inflammation is one of the most significant causes of several chronic diseases, which includes the expression of cytokines activating immune cells to up-regulate the inflammatory cascade. Polysaccharides from marine macroalgae are promising anti-inflammatory agents because of their potential to attenuate inflammatory cytokines. The triangular sea bell Turbinaria decurrens (Sargassaceae) among marine macroalgae is ubiquitous in oceanic waters, and a sulfated polygalactofucan SPTd-2 [â3-(α-L-fucp-(2-OSO3-)-(1 â 4)-α-L-fucp-(3-OAc)-(1 â 4)-ß-D-galp-(1â] was purified from the species. The studied polygalactofucan SPTd-2 exhibited anti-inflammatory activities against cyclooxygenase-2 (IC50 10.56 µM) and 5-lipoxygenase (IC50 3.36 µM) with a greater selectivity index (2.35) than ibuprofen (0.44), besides attenuating pro-inflammatory cytokine production, including tumor necrosis factor-α, transforming growth factor-ß, interleukin-2, 1ß, and interferon-γ. Quantitative real-time polymerase chain reaction displayed that SPTd-2 blocked the mRNA of interferon-γ and interleukin-2, in the human monocytic cell line THP-1. The results showed the potential of SPTd-2 to attenuate inflammation-associated disorders.
Asunto(s)
Citocinas , Interleucina-2 , Humanos , Citocinas/metabolismo , Interleucina-2/metabolismo , Interferón gamma/metabolismo , Sulfatos/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Antiinflamatorios/metabolismo , Inflamación/metabolismo , Macrófagos/metabolismoRESUMEN
Tumor protein or cellular tumor antigen p53, is considered a critical transcriptional regulation factor, which can suppress the growth of tumor cells by activating other functional genes. The current study appraised the p53 activation pathways, which could be used as an alternative therapeutic strategy for the treatment of hepatocellular and ductal carcinoma. Algal polysaccharides have been used as emerging sources of bioactive natural pharmacophores. A sulfated galactofucan characterized as [â1)-O-4-sulfonato-α-fucopyranose-(3 â 1)-α-fucopyranose-(3â] as the main branch with [â1)-6-O-acetyl-ß-galactopyranose-(4â] as side chain isolated from marine macroalga Turbinaria ornata exhibited prospective apoptosis on HepG2 (hepatocellular carcinoma) and MCF7 (ductal carcinoma) cells. Annexin V-fluorescein isothiocyanate-propidium iodide study displayed higher early apoptosis in MCF7 and HepG2 cell lines (56 and 24.2%, respectively) treated with TOP-3 (at IC50 concentration) than those administered with standard camptothecin. Upregulation of the p53 gene expression was perceived in TOP-3 treated HepG2 and MCF7 cells.
Asunto(s)
Carcinoma Ductal , Carcinoma Hepatocelular , Neoplasias Hepáticas , Phaeophyceae , Polisacáridos , Apoptosis , Camptotecina/farmacología , Carcinoma Ductal/tratamiento farmacológico , Carcinoma Hepatocelular/tratamiento farmacológico , Fucosa , Galactosa , Células Hep G2 , Humanos , Isotiocianatos , Neoplasias Hepáticas/tratamiento farmacológico , Phaeophyceae/química , Polisacáridos/química , Polisacáridos/farmacología , Algas Marinas/química , Sulfatos/química , Proteína p53 Supresora de Tumor/metabolismoRESUMEN
Dipeptidyl-peptidase-4 is a multifunctional ectoenzyme, which is implicated with hyperglycemic pathophysiology. Therefore, dipeptidyl-peptidase-4 inhibitors could be used as an attractive therapeutic strategy in blood-glucose homeostasis to attenuate the pathophysiologies of diabetes. A sulfated galactofucan characterized as [â1)-O-4-sulfonato-α-fucopyranosyl-(2â1)-O-2-sulfonato-α-fucopyranose-(3â] along with a branch of [â1)-6-O-methyl-ß-galactopyranosyl-(4â] unit at the C-4 position of O-2-sulfonato-α-fucopyranose, isolated from the seaweed Padina tetrastromatica, exhibited prospective attenuation property against dipeptidyl-peptidase-4 (IC50 0.25 mg mL-1). The studied sulfated galactofucan exhibited potential inhibitory properties against carbolytic enzymes α-amylase (IC50 0.98 mg mL-1) and α-glucosidase (IC50 0.87 mg mL-1) in comparison with the standard antidiabetic agent acarbose, along with radical scavenging activities. The seaweed-originated galactofucan could be developed as a promising natural therapeutic lead against hyperglycemic disorder.
Asunto(s)
Phaeophyceae , Algas Marinas , Sulfatos , Péptido Hidrolasas , Estudios Prospectivos , alfa-Glucosidasas , Hipoglucemiantes/farmacologíaRESUMEN
Bioactive compounds with angiotensin-I converting enzyme attenuation potential are deemed as therapeutic agents for hypertension owing to their capacity to suppress the conversion of angiotensin-I into the vasoconstrictor angiotensin-II. In an aim to develop natural angiotensin-I converting enzyme (ACE-I) inhibitors from marine algae, three 6, 6-spiroketals, spirornatas A-C were isolated from the organic extract of the spiny brown marine macroalga Turbinaria ornata (Turner) (family Sargassaceae). Spirornata A exhibited comparatively greater ACE-I attenuation potential (IC50 4.5 µM) than those displayed by other studied spiroketals (IC50 4.7-4.9 µM), and its activity was comparable to the ACE inhibitory agent captopril (IC50 4.3 µM). Greater antioxidant properties of spirornata A against oxidants (IC50 1.1-1.3 mM) also substantiated its potential attenuation property against ACE-I. Structure-activity correlation studies showed that electronic properties (topological polar surface area, 71) and balanced hydrophilic-lipophilic parameters (partition coefficient of logarithmic octanol-water â¼3.2) of spirornata A appeared to play pivotal roles in the inhibition of the targeted enzyme. Predicted drug-likeness and other physicochemical parameters appeared to attribute to the acceptable oral bioavailability of spiroketal derivatives. Additionally, the least binding energy of spirornata A with ACE-I (-10.5 kcal/mol) coupled with the maximum number of hydrogen-bonding interactions with allosteric sites of the zinc-dependent dicarboxypeptidyl peptidase could recognize its potential therapeutic application against hypertensive diseases.
Asunto(s)
Antihipertensivos , Phaeophyceae , Angiotensinas , Antihipertensivos/farmacología , Furanos , Peptidil-Dipeptidasa A , Compuestos de EspiroRESUMEN
Organic extract of the brown seaweed Turbinaria conoides (Sargassaceae) was chromatographically fractionated to yield an undescribed furanyl-substituted isochromanyl metabolite, named as turbinochromanone, which was characterized as methyl 4-[(3S)-8-{[(3R)-4-ethyl-2,3-dihydrofuran-3-yl]methyl}-1-oxo-3,4-dihydro-1H-2-benzopyran-3-yl]butanoate. The isochromanyl derivative possessed comparable attenuation potential against 5-lipoxygenase (IC50 3.70â µM) with standard 5-lipoxygenase inhibitor drug zileuton (IC50 2.41â µM). Noticeably, the index of anti-inflammatory selectivity of turbinochromanone (â¼1.7) was considerably greater than that exhibited by the standard agent diclofenac (1.06). Antioxidant properties of turbinochromanone against oxidants (IC50 â¼24â µM) further supported its potential anti-inflammatory property. Greater electronic properties (topological polar surface area of 61.8) along with comparatively lesser docking parameters of the studied compound with aminoacyl residues of targeted enzymes (cyclooxygenase-2 and 5-lipoxygenase) (binding energy of -11.05 and -9.40â kcal mol-1 , respectively) recognized its prospective anti-inflammatory potential. In an aim to develop seaweed-based natural anti-inflammatory leads, the present study isolated turbinochromanone as promising 5-lipoxygenase and cyclooxygenase-2 inhibitor, which could be used for pharmaceutical and biotechnological applications.
Asunto(s)
Antiinflamatorios/química , Cromanos/química , Algas Marinas/química , Antiinflamatorios/aislamiento & purificación , Antiinflamatorios/metabolismo , Antioxidantes/química , Araquidonato 5-Lipooxigenasa/química , Araquidonato 5-Lipooxigenasa/metabolismo , Sitios de Unión , Cromanos/aislamiento & purificación , Cromanos/metabolismo , Ciclooxigenasa 2/química , Ciclooxigenasa 2/metabolismo , Furanos/química , Conformación Molecular , Simulación del Acoplamiento Molecular , Extractos Vegetales/química , Estructura Terciaria de Proteína , Algas Marinas/metabolismo , TermodinámicaRESUMEN
Green marine macroalgae, particularly Ulva lactuca, is an essential constituent of the cuisines in many Asian countries. The present work aims to separate a bioactive pyrone attached benzochromene analogue, named as ulvapyrone from the organic extract of U. lactuca, followed by its structural characterisation as 2-{(6a'-hydroxyethyl-4'-methyltetrahydro-2H-pyran-2'-one)-6'-yl}-4-methyl-7-ethylacetate-8-hydroxy-7, 8-dihydrobenzo [de]chromene. Ulvapyrone exhibited prospective inhibition property against arachidonate 5-lipoxygenase (IC50 â¼1 mg mL-1) comparable to that demonstrated by ibuprofen (IC50 0.9 mg mL-1), which connoted its anti-inflammatory activity. The studied benzochromene exhibited promising antioxidant potential (IC50 0.5-0.6 mg mL-1), which further reinforced its attenuation property against 5-lipoxygenase. Bioactivities of ulvapyrone were linearly correlated with electronic parameter (topological polar surface area â¼102) along with less binding energy (-8.22 kcal mol-1) with the allosteric site of 5-lipoxygenase. In silico predictions of physicochemical parameters along with absorption, distribution, metabolism and excretion could recognise the acceptable oral bioavailability of ulvapyrone.
Asunto(s)
Chlorophyta , Ulva , Antiinflamatorios/farmacología , Araquidonato 5-Lipooxigenasa , Chlorophyta/química , Estudios Prospectivos , Pironas , Ulva/químicaRESUMEN
Polymeric ß-chitosan allomorph characterized by parallel arrangement of linear polysaccharide comprised of ß-(1 â 4)-linked-D-glucosamine and N-acetyl-D-glucosamine was isolated and characterized from the gladius of Indian Ocean Squid (Uroteuthis duvaucelii) and spineless cuttlefish (Sepiella inermis). The ß-chitosan from U. duvaucelii displayed considerably greater attenuation potential against hydroxymethylglutaryl coenzyme-A reductase, dipeptidyl peptidase-4, I converting enzyme, and 5-lipoxygenase (IC50 0.15-0.53 mg mL-1) than those exhibited by α-chitosan of comparable molecular weight. Comparatively lesser conformational rigidity of ß-chitin could result in its greater susceptibility to deacetylation (86-87%) contrasted to the α-allomorph (~83%), consequently delivering enhanced functionalities than those exhibited by α-chitosan. Porous ß-chitosan scaffolds displayed an average pore size of lesser than 50 µm, and its binding capacity was significantly higher than that exhibited by α-chitosan (p < 0.05). Potential pharmacological activities reinforced by lesser binding affinities and intermolecular energy of ß-chitosan with the target enzymes recognized its prospective biomedical applications.
Asunto(s)
Exoesqueleto/química , Quitosano/farmacología , Decapodiformes/química , Animales , Dominio Catalítico , Quitosano/química , Quitosano/metabolismo , Decapodiformes/anatomía & histología , Enzimas/química , Enzimas/metabolismo , Simulación del Acoplamiento Molecular , Porosidad , Unión ProteicaRESUMEN
Naturally occurring polysaccharide-structured nanoparticles have developed as promising materials for treatment of bone health disorders. Silver nanoparticle (ST-AgNP) structured from sulfated polygalacto-fucopyranose comprising of recurring structural entities of 2-SO3-α-(1 â 3)-fucopyranose and 6-O-acetyl-ß-(1 â 4)-galactopyranose isolated from marine macroalga Sargassum tenerrimum demonstrated potential activities associated with osteogenesis. Subsequent treatment with ST-AgNP, activity of alkaline phosphatase (63 mU/mg) was raised in osteoblast stem cells (human mesenchymal, hMSC) than that in control (30 mU/mg). Intense growth of mineralized nodule on the surface of hMSC was apparent following treatment with ST-AgNP. Increased population of bone morphogenic protein-2 (23%) and osteocalcin+ cells (50%) on M2 macrophages were apparent following treatment with ST-AgNP (0.25 mg/mL). Glucocorticoid-induced in vivo animal model studies of ST-AgNP exhibited significant recovery of serum biochemical parameters along with serum estradiol and parathyroid hormone compared to disease control. Disease-induced groups treated with ST-AgNP showed the disappearance of osteoporotic cavities in the trabecular bone. Following treatment with ST-AgNP, serum calcium and phosphorus contents were significantly recovered.
Asunto(s)
Fucosa/uso terapéutico , Galactanos/uso terapéutico , Glucocorticoides/efectos adversos , Nanopartículas/química , Osteoporosis/inducido químicamente , Osteoporosis/tratamiento farmacológico , Fosfatasa Alcalina/metabolismo , Animales , Antioxidantes/farmacología , Peso Corporal/efectos de los fármacos , Proteína Morfogenética Ósea 2/metabolismo , Calcificación Fisiológica/efectos de los fármacos , Espectroscopía de Resonancia Magnética con Carbono-13 , Línea Celular , Supervivencia Celular/efectos de los fármacos , Digestión/efectos de los fármacos , Conducta Alimentaria/efectos de los fármacos , Femenino , Fémur/efectos de los fármacos , Fémur/patología , Fucosa/aislamiento & purificación , Fucosa/farmacología , Galactanos/aislamiento & purificación , Galactanos/farmacología , Humanos , Células Madre Mesenquimatosas/efectos de los fármacos , Osteoblastos/efectos de los fármacos , Osteocalcina/metabolismo , Espectroscopía de Protones por Resonancia Magnética , Ratas Wistar , Espectrometría por Rayos X , Espectrofotometría UltravioletaRESUMEN
Intertidal marine brown alga Turbinaria conoides (J.Agardh) Kützing (family Sargassaceae) is considered as one of the largely abundant species, available in the coastal zones of the Indian subcontinent. Bioactivity-guided chromatographic fractionation of the organic extract of T. conoides resulted in three previously undescribed macrocyclic lactone homologues, named as conoidecyclics A-C. Conoidecyclic A displayed greater attenuation potential against cyclooxygenase-2 (IC50 1.75 mM) and 5-lipoxygenase (IC50 4.24 mM) in comparison with other analogues. Conoidecyclic A exhibited higher attenuation potential against 5-lipoxygenase than that displayed by an anti-inflammatory agent, ibuprofen (IC50 4.51 mM). The higher selectivity index of conoidecyclic A (1.79) recognized its selective attenuation potential against the inducible cyclooxygenase-2 enzyme. Inhibition potential of conoidecyclic A against angiotensin converting enzyme-I (IC50 1.23 mM) and protein tyrosine phosphatase-1B (IC50 1.39 mM) were non-competitive, as deduced by kinetic studies. In-silico molecular modeling study of conoidecyclic A with the allosteric sites of the targeted enzymes exhibited least binding energy of -14.51 to -11.27 kcal mol-1 compared to those exhibited by other studied macrolide homologues. Reaction kinetic studies of conoidecyclic A coupled with lesser apparent Vmax inferred that it could efficiently bind with the allosteric site of targeted enzymes in a non-competitive manner to diminish the reaction velocity resulting in enzyme inhibition. Drug-likeness and predictive pharmacokinetic parameters of conoidecyclic A exhibited an acceptable oral bioavailability. These reports inferred that conoidecyclic A encompassing pentacosa macrocyclic moiety could be a promising therapeutic lead to inhibit the enzymes related to the development and progression of pathological conditions leading to inflammation, hypertension and type-2 diabetes.
Asunto(s)
Phaeophyceae , Algas Marinas , Antioxidantes , Cinética , Macrólidos , Estudios ProspectivosRESUMEN
A heterotrophoic Bacillus amyloliquefaciens MTCC12713 isolated from an intertidal macroalga Kappaphycus alverezii displayed promising antibacterial activities against multidrug-resistant bacteria. Genome mining of the bacterium predicted biosynthetic gene clusters coding for antibacterial secondary metabolites. Twenty-one membered macrocyclic lactones, identified as difficidin analogues bearing 6-hydroxy-8-propyl carboxylate, 9-methyl-19-propyl dicarboxylate, 6-methyl-9-propyl dicarboxylate-19-propanone, and (20-acetyl)-6-methyl-9-isopentyl dicarboxylate (compounds 1 through 4) functionalities were purified through bioassay-guided fractionation. The difficidin analogues exhibited bactericidal activities against vancomycin-resistant Enterococcus faecalis, methicillin-resistant Staphylococcus aureus, and other drug-resistant strains, such of Klebsiella pneumonia and Pseudomonas aeruginosa with the minimum inhibitory concentration of about 2-9 × 10-3 µM. A plausible enzyme-catalyzed biosynthetic pathway that is generated through addition of acrylyl initiator unit by repetitive decarboxylative Claisen condensation modules with malonate units was recognized, and their structures were corroborated with gene organization of the dif operon, which could comprehend dif A-O (~ 70 kb). Drug-likeness score for 5-ethoxy-28-methyl-(9-methyl-19-propyl dicarboxylate) difficidin (compound 2, 0.35) was greater than those of other difficidin analogues, which corroborated the potential in vitro antibacterial properties of the former. The present study demonstrated the potential of difficidin analogues for pharmaceutical and biotechnological uses against the bottleneck of emergent drug-resistant pathogens. KEY POINTS: ⢠Difficidins were isolated from marine alga associated Bacillus amyloliquefaciens. ⢠Whole-genome mining of bacterial genome predicted biosynthetic gene clusters. ⢠Greater drug-likeness for difficidin 2 confirmed its potent antibacterial activity.
Asunto(s)
Bacillus , Staphylococcus aureus Resistente a Meticilina , Policétidos , Algas Marinas , Antibacterianos/farmacología , Lactonas , Pruebas de Sensibilidad MicrobianaRESUMEN
Consumption of marine alga-based polysaccharides as additional functional foods can endow with health benefits by diminishing the risk of chronic diseases. A polygalacto-fucopyranose characterized as [â1)-2, 4-SO3-α-Fucp-(3 â 1)-{2-SO3-α-Fucp-(3â}] with [(4 â 1)-6-OAc-ß-Galp-(4â] side chain isolated from marine alga Sargassum wightii exhibited potential antihypertensive activity. Upon treatment with studied polygalactofucan (50 mg/kg BW), serum hypertension biomarkers troponin-T (1.3 pg/mL), troponin-I (1.2 µg/dL) and angiotensin-II converting enzyme (0.18 pg/mL) were significantly recovered in hypertensive rats compared to disease control. Serum cardiovascular risk indices of diseased rats were significantly decreased (< 10%, p < 0.05) after administration of the studied galactofucan (50 mg/kg BW) related to hypertension group (> 17%), and were comparable with standard antihypertensive agent telmisartan (8.3-10.2% at 2 mg/kg BW). The studied compound was safe for consumption as obvious from the high LD50 value (>5 g/kg), and could be developed as a prospective functional food ingredient attenuating the pathophysiological attributes causing hypertension-related conditions.
Asunto(s)
Antihipertensivos/farmacología , Presión Sanguínea/efectos de los fármacos , Fucosa/farmacología , Hipertensión/tratamiento farmacológico , Sargassum , Animales , Antihipertensivos/aislamiento & purificación , Antihipertensivos/toxicidad , Cloruro de Cadmio , Modelos Animales de Enfermedad , Descubrimiento de Drogas , Fucosa/análogos & derivados , Fucosa/aislamiento & purificación , Fucosa/toxicidad , Hipertensión/inducido químicamente , Hipertensión/fisiopatología , Dosificación Letal Mediana , Masculino , Ratas Wistar , Sargassum/química , Telmisartán/farmacologíaRESUMEN
Naturally derived polysaccharide biopolymer-based nanoparticles with their size and drug release potentials have appeared as promising biomaterials for osteogenic differentiation. A metallic nanoparticle (GS-AgNP) prepared from a sulfated polygalactan characterized as â3)-2-O-methyl-O-6-sulfonato-ß-d-galactopyranosyl-(1 â 4)-2-O-methyl-3,6-anhydro-α-d-galactopyranose-(1â isolated from the marine macroalga Gracilaria salicornia exhibited a prospective osteogenic effect. Upon treatment with the studied GS-AgNP, alkaline phosphatase activity (88.9 mU/mg) was significantly elevated in human mesenchymal osteoblast stem cells (hMSCs) compared to that in the normal control (33.7 mU/mg). A mineralization study of GS-AgNPs demonstrated an intense mineralized nodule formation on the hMSC surface. A fluorescence-activated cell sorting study of osteocalcin and bone morphogenic protein-2 (BMP-2) expression resulted in an increased population of osteocalcin (78.64%) and BMP-2-positive cells (46.10%) after treatment with GS-AgNPs (250 µg/mL) on M2 macrophages. A time-dependent cell viability study of GS-AgNPs exhibited its non-cytotoxic nature. The studied polygalactan-built nanoparticle could be developed as a promising bioactive pharmacophore against metabolic bone disorder and the treatment for osteogenesis therapy.
Asunto(s)
Células Madre Mesenquimatosas , Nanopartículas , Fosfatasa Alcalina , Diferenciación Celular , Células Cultivadas , Humanos , Osteogénesis , Estudios ProspectivosRESUMEN
Chemical analysis of the organic extract from intertidal brown seaweed Sargassum ilicifolium (family Sargassaceae) characterised an undescribed xenicane-type diterpenoid sargilicixenicane, elucidated as 3-(17-hydroxy-14-methylhept-13-en-10-yl)-6-methylhexahydro-1H-cyclonona[c]furan-4,19-diyl diacetate (compound 1). The studied compound exhibited prospective free radical quenching potential (IC50 1.2-1.4 mM) in comparison with commercial antioxidant (α-tocopherol, IC50 > 1.40 mM). Attenuation property of sargilicixenicane against pro-inflammatory enzyme, 5-lipoxygenase (IC50 4.70 mM) was comparable with that displayed by the non-steroidal anti-inflammatory agent ibuprofen (IC50 4.51 mM). Greater selectivity index displayed by the studied xenicane-type diterpenoid (1.42) than that exhibited by ibuprofen (0.44) recognised the selective attenuation potential of the former against the inducible cyclooxygenase-2 and 5-lipoxygenase enzymes. Higher electronic parameters (topological polar surface area, 82.06) and balanced hydrophobic-hydrophilic property (octanol-water partition coefficient 2.94) coupled with docking score (-11.17 kcal mol-1) and lower binding energy (-9.61 kcal mol-1) with the active site of 5-lipoxygenase supported the significant anti-inflammatory properties of the studied xenicane-type diterpenoid.
Asunto(s)
Diterpenos , Sargassum , Algas Marinas , Antiinflamatorios/farmacología , AntioxidantesRESUMEN
The organic extract of Turbinaria conoides, a brown seaweed harvested from the Gulf of Manner region of Indian peninsular was chromatographically fractionated to yield three substituted 2H-pyranoids, namely methyl-21-yl-[5', 6'- dihydro-5'-yl-{54-(4-hydroxybenzoyl)-oxy-(52-methylbutyl)}-3'-methyl-2H-pyran]-21-methyl butanoate (1), 11-[(3', 6'-dihydro-4'-methyl-2'-oxo-2H-pyran-3'-yl)methyl]-10-methylhexyl benzoate (2), and [6-ethyl-3,4-dimethyl-(tetrahydro-2', 2', 6'-trimethyl-2H-pyran-3'-yl)-2,5-cycloheptadiene]-1-propanoate (3). The compounds 1 and 2 bearing 2H-pyranyl-4-hydroxybenzoyl and 2H-pyranyl-10-methylhexylbenzoate moieties exhibited potential antioxidant activities (IC50 0.54-0.69 mg mL-1) as commercial antioxidant (α-tocopherol IC50 0.63-0.73 mg mL-1). Likewise, potential bioactivity of the 2H-pyran derivative, 1 against 5-lipoxygenase (IC50 â¼ 1 mg mL-1) along with higher index of selectivity (COX-1 inhibitoryIC50/COX-2 inhibitoryIC50 1.88) indicated their selective anti-inflammatory properties against inducible inflammatory mediators than that displayed by commercially available non-steroidal anti-inflammatory drug (ibuprofen, 0.44). Structure activity relationship analysis of the studied compounds showed that the antioxidative and anti-inflammatory properties were directly proportional to their electronic properties. The previously undescribed 2H-pyranoids might constitute as potential antioxidative and anti-inflammatory pharmacophores for medicinal applications. [Formula: see text].
Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Antioxidantes/farmacología , Phaeophyceae/química , Piranos/química , Relación Estructura-Actividad , Antiinflamatorios no Esteroideos/química , Antioxidantes/química , Inhibidores de la Ciclooxigenasa 2/química , Inhibidores de la Ciclooxigenasa 2/farmacología , Inhibidores de la Ciclooxigenasa/química , Inhibidores de la Ciclooxigenasa/farmacología , Evaluación Preclínica de Medicamentos , Inhibidores de la Lipooxigenasa/química , Inhibidores de la Lipooxigenasa/farmacología , Espectroscopía de Resonancia Magnética , Estructura Molecular , Algas Marinas/químicaRESUMEN
Sugar-based low-molecular-weight gelators (LMWGs) have been used for various applications for a long time. Herein, structurally simple, ester-protected arabinosides are reported as low-molecular-weight organogelators (LMOGs) that are able to gel aromatic solvents, as well as petrol and diesel. Studies on the mechanical strength of the gels, through detailed rheological experiments, indicate that gels from the 1,2-dibenzoylated arabinose gelator possess better mechanical properties than those from the 1,2-diacetylated gelator. These results are interpreted in terms of the tendency of the former to form fibers with comparatively lower diameter than those of the latter, based on detailed field-emission SEM and AFM studies. Investigations of the interactions responsible for the self-assembly of gelators through IR spectroscopy and wide-angle X-ray scattering reveal that the primary interactions responsible are hydrogen bonds between the hydroxyl groups and ester C=O, which is absent in the solid state of the gelators. In addition, π interactions present in the 1,2-dibenzoylated derivative result in a more regular arrangement, which, in turn, leads to better mechanical properties of the gels compared with those of the 1,2-diacetylated gelator.